In the first quarter of 2012, Biofarm posted a net profit of RON6.67 million.
The company said total sales increased 23% on the year to RON33.4 million in the first three months, from RON27.2 million in the year-earlier period.
Operating profit was up 44% to RON10.4 million.
The company expects a full-year net profit of RON19 million in 2013, down roughly 10% from the previous year.
Biofarm has a share capital of RON109.4 million split into 1.09 billion shares with a face value of RON0.1.
Romanian regional investment funds SIF Oltenia (SIF5.RO), SIF Banat Crisana (SIF1.RO) and SIF Moldova (SIF2.RO) own together around 54% of Biofarm’s shares.
On the Bucharest bourse Tuesday, Biofarm closed up 3.06% at RON0.2257 a share, valuing the company at RON247.1 million. (EUR1=RON4.3311)